Citation

Wu L, Zhang C, He C, Qian D, Lu L, Sun Y, Xu M, Zhuo J, Liu PCC, Klabe R, Wynn R, Covington M, Gallagher K, Leffet L, Bowman K, Diamond S, Koblish H, Zhang Y, Soloviev M, Hollis G, Burn TC, Scherle P, Yeleswaram S, Huber R, Yao W.: Discovery of Pemigatinib: A Potent and Selective Fibroblast Growth Factor Receptor (FGFR) Inhibitor. J Med Chem, Volume 64 (15), 2021

Authors

Bowman K, Burn TC, Covington M, Diamond S, Gallagher K, He C, Hollis G, Huber R, Klabe R, Koblish H, Leffet L, Liu PCC, Lu L, Qian D, Scherle P, Soloviev M, Sun Y, Wu L, Wynn R, Xu M, Yao W., Yeleswaram S, Zhang C, Zhang Y, Zhuo J

Journal

J Med Chem

Year

2021

DOI

10.1021/acs.jmedchem.1c00713

PubMed

34269576

Machine-readable

REST APIRDF